Literature DB >> 24677131

Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures.

Jasmohan S Bajaj1, Jacqueline G O'Leary, K Rajender Reddy, Florence Wong, Scott W Biggins, Heather Patton, Michael B Fallon, Guadalupe Garcia-Tsao, Benedict Maliakkal, Raza Malik, Ram M Subramanian, Leroy R Thacker, Patrick S Kamath.   

Abstract

UNLABELLED: Infections worsen survival in cirrhosis; however, simple predictors of survival in infection-related acute-on-chronic liver failure (I-ACLF) derived from multicenter studies are required in order to improve prognostication and resource allocation. Using the North American Consortium for Study of End-stage Liver Disease (NACSELD) database, data from 18 centers were collected for survival analysis of prospectively enrolled cirrhosis patients hospitalized with an infection. We defined organ failures as 1) shock, 2) grade III/IV hepatic encephalopathy (HE), 3) need for dialysis and mechanical ventilation. Determinants of survival with these organ failures were analyzed. In all, 507 patients were included (55 years, 52% hepatitis C virus [HCV], 15.8% nosocomial infection, 96% Child score ≥ 7) and 30-day evaluations were available in 453 patients. Urinary tract infection (UTI) (28.5%), and spontaneous bacterial peritonitis (SBP) (22.5%) were the most prevalent infections. During hospitalization, 55.7% developed HE, 17.6% shock, 15.1% required renal replacement, and 15.8% needed ventilation; 23% died within 30 days and 21.6% developed second infections. Admitted patients developed none (38.4%), one (37.3%), two (10.4%), three (10%), or four (4%) organ failures. The 30-day survival worsened with a higher number of extrahepatic organ failures, none (92%), one (72.6%), two (51.3%), three (36%), and all four (23%). I-ACLF was defined as ≥ 2 organ failures given the significant change in survival probability associated at this cutoff. Baseline independent predictors for development of ACLF were nosocomial infections, Model for Endstage Liver Disease (MELD) score, low mean arterial pressure (MAP), and non-SBP infections. Independent predictors of poor 30-day survival were I-ACLF, second infections, and admission values of high MELD, low MAP, high white blood count, and low albumin.
CONCLUSION: Using multicenter study data in hospitalized decompensated infected cirrhosis patients, I-ACLF defined by the presence of two or more organ failures using simple definitions is predictive of poor survival.
© 2014 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2014        PMID: 24677131      PMCID: PMC4077926          DOI: 10.1002/hep.27077

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  17 in total

Review 1.  Bacterial infections in end-stage liver disease: current challenges and future directions.

Authors:  Jasmohan S Bajaj; Jacqueline G O'Leary; Florence Wong; K Rajender Reddy; Patrick S Kamath
Journal:  Gut       Date:  2012-06-03       Impact factor: 23.059

2.  Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD) experience.

Authors:  Jasmohan S Bajaj; Jacqueline G O'Leary; K Rajender Reddy; Florence Wong; Jody C Olson; Ram M Subramanian; Geri Brown; Nicole A Noble; Leroy R Thacker; Patrick S Kamath
Journal:  Hepatology       Date:  2012-12       Impact factor: 17.425

3.  APACHE II: a severity of disease classification system.

Authors:  W A Knaus; E A Draper; D P Wagner; J E Zimmerman
Journal:  Crit Care Med       Date:  1985-10       Impact factor: 7.598

4.  Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study.

Authors:  Javier Fernández; Juan Acevedo; Miriam Castro; Orlando Garcia; Carlos Rodríguez de Lope; Daria Roca; Marco Pavesi; Elsa Sola; Leticia Moreira; Anibal Silva; Tiago Seva-Pereira; Francesco Corradi; Jose Mensa; Pere Ginès; Vicente Arroyo
Journal:  Hepatology       Date:  2012-04-04       Impact factor: 17.425

5.  Renal dysfunction is the most important independent predictor of mortality in cirrhotic patients with spontaneous bacterial peritonitis.

Authors:  Puneeta Tandon; Guadalupe Garcia-Tsao
Journal:  Clin Gastroenterol Hepatol       Date:  2010-12-08       Impact factor: 11.382

6.  Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis.

Authors:  Vasiliki Arvaniti; Gennaro D'Amico; Giuseppe Fede; Pinelopi Manousou; Emmanuel Tsochatzis; Maria Pleguezuelo; Andrew Kenneth Burroughs
Journal:  Gastroenterology       Date:  2010-06-14       Impact factor: 22.682

Review 7.  Acute-on chronic liver failure.

Authors:  Rajiv Jalan; Pere Gines; Jody C Olson; Rajeshwar P Mookerjee; Richard Moreau; Guadalupe Garcia-Tsao; Vicente Arroyo; Patrick S Kamath
Journal:  J Hepatol       Date:  2012-06-28       Impact factor: 25.083

Review 8.  Immune dysfunction and infections in patients with cirrhosis.

Authors:  Alexander R Bonnel; Chalermrat Bunchorntavakul; K Rajender Reddy
Journal:  Clin Gastroenterol Hepatol       Date:  2011-03-11       Impact factor: 11.382

9.  High prevalence of antibiotic-resistant bacterial infections among patients with cirrhosis at a US liver center.

Authors:  Puneeta Tandon; Angela Delisle; Jeffrey E Topal; Guadalupe Garcia-Tsao
Journal:  Clin Gastroenterol Hepatol       Date:  2012-08-17       Impact factor: 11.382

10.  Patients with cirrhosis and denied liver transplants rarely receive adequate palliative care or appropriate management.

Authors:  Zafrina Poonja; Amanda Brisebois; Sander Veldhuyzen van Zanten; Puneeta Tandon; Glenda Meeberg; Constantine J Karvellas
Journal:  Clin Gastroenterol Hepatol       Date:  2013-08-24       Impact factor: 11.382

View more
  123 in total

1.  Proton pump inhibitor prescription abuse and sepsis in cirrhosis.

Authors:  Antonio Picardi; Umberto Vespasiani-Gentilucci
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-02-06

Review 2.  Bacterial Infection in Patients with Cirrhosis: Don't Get Bugged to Death.

Authors:  Mary D Cannon; Paul Martin; Andres F Carrion
Journal:  Dig Dis Sci       Date:  2020-01       Impact factor: 3.199

Review 3.  Liver transplantation in acute on chronic liver failure: challenges and an algorithm for patient selection and management.

Authors:  Viniyendra Pamecha; Senthil Kumar; Kishore G S Bharathy
Journal:  Hepatol Int       Date:  2015-07-10       Impact factor: 6.047

Review 4.  Acute-on-Chronic Liver Failure.

Authors:  Sumeet K Asrani; Douglas A Simonetto; Patrick S Kamath
Journal:  Clin Gastroenterol Hepatol       Date:  2015-07-15       Impact factor: 11.382

5.  Bacterial infections in cirrhotic patients.

Authors:  Bilge Örmeci Baş; Ayhan Hilmi Çekin
Journal:  Turk J Gastroenterol       Date:  2019-08       Impact factor: 1.852

Review 6.  Acute on Chronic Liver Failure-What is in a 'Definition'?

Authors:  Anil C Anand; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2016-09-01

Review 7.  Grand Rounds: Alcoholic Hepatitis.

Authors:  Ashwani K Singal; Alexandre Louvet; Vijay H Shah; Patrick S Kamath
Journal:  J Hepatol       Date:  2018-06-13       Impact factor: 25.083

8.  Acute-on-chronic liver failure.

Authors:  Rahul Kumar; Gautam Mehta; Rajiv Jalan
Journal:  Clin Med (Lond)       Date:  2020-09       Impact factor: 2.659

Review 9.  Acute-on-chronic liver failure: Pathogenesis, prognostic factors and management.

Authors:  Sara Blasco-Algora; José Masegosa-Ataz; María Luisa Gutiérrez-García; Sonia Alonso-López; Conrado M Fernández-Rodríguez
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

Review 10.  Overview on acute-on-chronic liver failure.

Authors:  Jing Zhang; Shan Gao; Zhongping Duan; Ke-Qin Hu
Journal:  Front Med       Date:  2016-03-14       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.